Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miroslav Hebelka"'
Autor:
Elisabeth Ek, Miroslav Hebelka, Ann-Margreth Olinder-Nielsen, Kjell Alestig, Torsten Sandberg, Eva Johansson, Tönnes Eilard
Publikováno v:
Scandinavian journal of infectious diseases. 29(2)
A prospective, coordinated, randomized multicentre trial was conducted to determine whether tobramycin 160 mg intravenously (i.v.) once daily for 2 days would improve the efficacy of cefotaxime 1 g i.v. twice daily for 2 days followed by a 10-day cou
Autor:
Zoltan Varga, Bengt A. Christensson, Peet Tüll, Miroslav Hebelka, Ingrid Nilsson-Ehle, Lars Nyman, Rune Svensson, Bengt Ljungberg, Otto Paulsen
Publikováno v:
Scandinavian journal of infectious diseases. 24(2)
The efficacy and tolerance of roxithromycin 150 mg b.i.d. were compared with those of erythromycin stearate 500 mg b.i.d. in patients with lower respiratory tract infections. Out of 86 patients recruited for the study, 79 were evaluable for tolerance
Publikováno v:
Scandinavian journal of infectious diseases. 7(2)
A 63-year-old woman developed pneumococcal meningitis during cephalothin treatment for pneumococcal septicaemia. The poor penetration of this antibiotic over the blood-brain barrier makes it unsuitable for the therapy of meningitis. If cephalothin is